Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› South Brisbane
Clinical trial register · Australia

Clinical Trials in South Brisbane, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1096 Adelaide 565 Sydney 508 Westmead 416 Clayton 407
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca22 AbbVie18 Children's Oncology Group17 Janssen Research & Development, LLC11 National Cancer Institute (NCI)9
Site location
Melbourne1096 Adelaide565 Sydney508 Westmead416 Clayton407
All 401 locations
Target enrolment
to

Trials with a site in South Brisbane

308 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Camperdown, Chermside, Greenslopes, South Brisbane, Adelaide, Frankston, Murdoch, Nedlands
2026-12-16
Not yet open
AbbVie
Phase 3
520
Wollongong, Benowa, South Brisbane, Melbourne, Richmond, Murdoch, Nedlands
2026-11-30
Recruiting
Biomed Industries, Inc.
Phase 3
210
Camperdown, South Brisbane, Heidelberg West, Parkville
2026-09-30
Recruiting
A Study in Adults With Geographic Atrophy
NCT07606365Geographic Atrophy
DrugSTL303
Sitala Bio LTD
Phase 2
300
Sydney, Westmead, South Brisbane, Adelaide, East Melbourne, Parkville
2026-09-11
Recruiting
BeOne Medicines
Phase 1
100
South Brisbane, Malvern
2026-09-02
Not yet open
Suzhou Forlong Biotechnology Co., Ltd
Phase 1
29
South Brisbane
2026-09
Recruiting
Soufflé Therapeutics, Inc.
Phase 1/2
90
Concord, Liverpool, Brisbane, South Brisbane, Melbourne
2026-09
Recruiting
Hoffmann-La Roche
Phase 3
100
South Brisbane, Parkville, Nedlands
2026-08-18
Recruiting
VarmX B.V.
Phase 3
800
Herston, South Brisbane, Southport, Fitzroy, Melbourne, Murdoch
2026-08-18
Not yet open
Biomed Industries, Inc.
Phase 2
224
Brookvale, Saint Leonards,, South Brisbane, Camberwell, Heidelberg West
2026-08-15
Recruiting
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
170
North Ryde, St Leonards, South Brisbane, Adelaide, Richmond
2026-08-13
Recruiting
iVEAcare
Not applicable
30
Herston, South Brisbane, Clayton, Fitzroy, Heidelberg, Melbourne, Parkville
2026-07-29
Recruiting
Verastem, Inc.
Phase 2
150
Macquarie Park, Waratah, South Brisbane, Kurralta Park
2026-07-28
Recruiting
CStone Pharmaceuticals
Phase 1
310
Darlinghurst, North Ryde, Waratah, South Brisbane, Fitzroy, Nedlands
2026-07-16
Recruiting
AstraZeneca
Phase 3
915
Auchenflower, Ballarat, Clayton, Darlinghurst, Elizabeth Vale, South Brisbane, St Albans
2026-07-16
Recruiting
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
NCT07644559Pancreatic Ductal Adenocarcinoma (PDAC), G12D Mutated KRAS
DrugsVS-7375·Cetuximab
Verastem, Inc.
Phase 2
185
Sydney, Waratah, Hyde Park, Kurralta Park, South Brisbane
2026-06-16
By invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
NCT07652294Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
DrugsSPY001·SPY002·SPY003
Spyre Therapeutics, Inc.
Phase 2
645
Concord, South Brisbane
2026-06-08
Recruiting
FibroBiologics
Phase 1/2
120
Coffs Harbour, New Lambton Heights, Saint Leonards, Wollongong, South Brisbane, West Mackay, Clayton, Melbourne
2026-06-01
Recruiting
Novo Nordisk A/S
Phase 3
2,500
Campbelltown, Gosford, Liverpool, Merewether, Birtinya, South Brisbane, Camberwell
2026-05-21
Recruiting
Lumos Pharma
Phase 3
150
South Brisbane, Clayton, Parkville
2026-05-20
Recruiting
Ipsen
Phase 3
350
Saint Leonards, Westmead, Birtinya, South Brisbane, Adelaide, Heidelberg, Melbourne, Nedlands
2026-05-14
Recruiting
EMD Serono Research & Development Institute, Inc.
Phase 3
1,020
St Leonards, Chermside, South Brisbane, Bedford Park
2026-05-06
Recruiting
Regeneron Pharmaceuticals
Phase 2
99
Brisbane, South Brisbane, Hobart
2026-05-06
Recruiting
Novo Nordisk A/S
Phase 3
300
Macquarie Park, Birtinya, South Brisbane, Adelaide, Crawley
2026-05-05
Recruiting
Novo Nordisk A/S
Phase 3
300
Macquarie Park, Birtinya, South Brisbane, Adelaide, Crawley
2026-05-05
Recruiting
Pfizer
Phase 3
2,400
Westmead, Brisbane, South Brisbane, Clayton, Parkville, Nedlands
2026-05-04
Recruiting
Merck Sharp & Dohme LLC
Phase 3
590
Macquarie, South Brisbane
2026-04-23
Recruiting
Ionis Pharmaceuticals, Inc.
Phase 3
20
South Brisbane, Clayton
2026-04-21
Active, closed
Sanofi Pasteur, a Sanofi Company
Observational
100
Gold Coast, South Brisbane
2026-04-20
Recruiting
Sanofi
Phase 1
570
Griffith, Herston, Morayfield, Sippy Downs, South Brisbane, Taringa
2026-04-15
Recruiting
Hoffmann-La Roche
Phase 3
100
South Brisbane, Parkville, Nedlands
2026-04-15
Recruiting
BeOne Medicines
Phase 1
84
Frenchs Forest, Liverpool, South Brisbane, Malvern
2026-04-13
Recruiting
Study in Advanced Solid Tumor Patients
NCT07300943Advanced Solid Tumor
Callio Therapeutics
Phase 1/2
306
Randwick, South Brisbane, Box Hill, Heidelberg, Melbourne, Nedlands
2026-03-19
Recruiting
University of Sydney
Phase 3
540
Lambton, Randwick, Westmead, South Brisbane, Woolloongabba, Adelaide, Clayton, Murdoch
2026-03-13
Recruiting
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
NCT07335497Locally Advanced / Metastatic Solid Tumors
Crescent Biopharma, Inc.
Phase 1/2
290
South Brisbane
2026-02-17
By invitation
Immunovant Sciences GmbH
Phase 2
372
South Brisbane, Southport, Perth, St Leonards, Sydney
2026-01-26
Recruiting
Sanofi
Phase 3
751
South Brisbane, Salzburg, Vienna
2026-01-22
Recruiting
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
NCT07159841Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia
DrugAtumelnant
Crinetics Pharmaceuticals Inc.
Phase 2/3
153
Westmead, South Brisbane, Clayton, Nedlands
2026-01-22
Recruiting
DualityBio Inc.
Phase 1/2
127
Randwick, South Brisbane, Nedlands
2026-01-20
Recruiting
Kahr Bio Australia Pty Ltd
Phase 2
90
Woodville, Camperdown, Port Macquarie, Westmead, South Brisbane, Bedford Park, Clayton, Footscray
2026-01-16
Recruiting
Servier Bio-Innovation LLC
Phase 1
30
South Brisbane, Adelaide
2026-01-14
Recruiting
Stemline Therapeutics, Inc.
Phase 1
100
South Brisbane, Aberfoyle Park
2026-01-10
Recruiting
Novo Nordisk A/S
Phase 3
460
Westmead, South Brisbane, Nedlands
2026-01-08
Recruiting
Insmed Incorporated
Phase 3
344
Camperdown, Kingswood, New Lambton Heights, Westmead, Auchenflower, South Brisbane
2026-01-07
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
DrugsPF-08634404·Pembrolizumab
Pfizer
Phase 3
1,410
Kingswood, St Leonards, Birtinya, Gympie, Nambour, South Brisbane, Elizabeth Vale, Hobart
2026-01-06
Active, closed
Kailera
Phase 3
1,270
Bruce, Blacktown, Kanwal, Herston, Morayfield, South Brisbane, Camberwell
2025-12-30
Recruiting
A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry
NCT07194070Hemolytic Disease of the Fetus and Newborn
Janssen Research & Development, LLC
Observational
175
Parkville, South Brisbane
2025-12-17
Recruiting
Study of DONQ52 in Active Celiac Disease
NCT07239336Celiac Disease
Chugai Pharmaceutical
Phase 2
92
Campbelltown, North Sydney, Morayfield, Sippy Downs, South Brisbane, Box Hill, Parkville, Midland
2025-12-16
Recruiting
AstraZeneca
Phase 2
230
Camperdown, Clayton, Herston, Melbourne, South Brisbane
2025-12-10
Recruiting
AbbVie
Phase 2/3
490
Garran, Kogarah, South Brisbane, Hobart, Fitzroy, St Albans, Nedlands
2025-12-10
Recruiting
Incyte Corporation
Phase 3
466
Camperdown, Concors, Wollongong, South Brisbane, Townsville, Box Hill
2025-12-09
Active, closed
Boehringer Ingelheim
Phase 3
135
Westmead, South Brisbane, Clayton, Parkville
2025-12-09
Recruiting
AstraZeneca
Phase 3
1,100
Clayton, Darlinghurst, Gosford, Murdoch, South Brisbane
2025-12-04
Recruiting
Myeloid Therapeutics
Phase 1
60
Darlinghurst, Randwick, Waratah, South Brisbane, Adelaide, Melbourne, Nedlands
2025-11-25
Recruiting
Syndax Pharmaceuticals
Phase 3
468
Kingswood, Kogarah, Randwick, South Brisbane, Melbourne, Nedlands, Perth, Gosford
2025-11-25
Recruiting
AstraZeneca
Phase 2
435
Birtinya, Macquarie University, South Brisbane
2025-11-06
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
NCT07085767Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
DrugsPalazestrant·Ribociclib·Letrozole
Olema Pharmaceuticals, Inc.
Phase 3
1,000
Sydney, Waratah, South Brisbane, Adelaide, Clayton, Geelong, Heidelberg, Nedlands
2025-11-03
Recruiting
AstraZeneca
Phase 3
400
Gosford, Kogarah, South Brisbane, St Albans, Wollongong
2025-10-31
Recruiting
RAPT Therapeutics, Inc., a member of the GSK plc group of companies
Phase 2
100
Darlinghurst, Westmead, South Brisbane, North Adelaide, Clayton, Parkville, Nedlands, Perth
2025-10-22
Recruiting
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
120
Adelaide, Parkville, South Brisbane
2025-10-20
Recruiting
Merck Sharp & Dohme LLC
Phase 3
675
Campbelltown, Frenchs Forest, Brisbane, South Brisbane, Frankston
2025-10-08
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Clayton, Concord, Fitzroy, Murdoch, New Lambton Heights, South Brisbane
2025-10-03
Recruiting
Sanofi
Phase 3
980
Birtinya, Nedlands, South Brisbane
2025-10-01
Recruiting
Janssen Research & Development, LLC
Phase 3
882
Clayton, Concord, Fitzroy, Murdoch, New Lambton Heights, Parkville, South Brisbane
2025-10-01
Recruiting
Genentech, Inc.
Phase 2
224
South Brisbane, Parkville VIC, Murdoch
2025-09-29
Recruiting
Pfizer
Phase 3
1,000
Orange, Wahroonga, South Brisbane, Kurralta Park, Nedlands
2025-09-28
Recruiting
BioNTech SE
Phase 1/2
880
Adelaide, Kogarah, Saint Leonards, South Brisbane, Tugun, Westmead
2025-09-22
Recruiting
Sanofi
Phase 3
942
Coffs Harbour, Tiwi, South Brisbane, Townsville, Traralgon, Osborne Park, Dunedin
2025-09-17
Recruiting
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
240
South Brisbane, Adelaide, Parkville
2025-08-11
Recruiting
AstraZeneca
Phase 3
700
Kingswood, Murdoch, Orange, South Brisbane, St Leonards, Waratah, Woolloongabba
2025-08-06
Recruiting
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
NCT06333899High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma, Infant Type Hemispheric Glioma
DrugLorlatinib
Nationwide Children's Hospital
Early Phase 1
15
Randwick, South Brisbane, Perth
2025-08-03
Recruiting
BioMarin Pharmaceutical
Phase 2
60
South Brisbane, Parkville
2025-07-30
Recruiting
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
NCT06838676Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG, Refractory DIPG, Recurrent DIPG
DrugACT001
Nationwide Children's Hospital
Phase 2
60
Randwick, South Brisbane, Melbourne, Perth
2025-07-10
Recruiting
AbbVie
Phase 1/2
602
Coffs Harbour, Port Macquarie, Westmead, South Brisbane, Adelaide, Fitzroy, Melbourne, West Perth
2025-06-30
Recruiting
AstraZeneca
Phase 2
987
Cairns, Nedlands, Norwood, Osborne Park, South Brisbane, Wollongong
2025-06-27
Active, closed
DBV Technologies
Phase 3
480
Westmead, South Brisbane, Parkville, Richmond, Nedlands
2025-06-24
Recruiting
Relay Therapeutics, Inc.
Phase 2
277
Randwick, South Brisbane, Clayton, Parkville
2025-06-13
Recruiting
BioNTech SE
Phase 3
480
Adelaide, Clayton, Gosford, Melbourne, Nowra, Saint Albans, South Brisbane, Wollongong
2025-06-10
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
156
South Brisbane, Heidelberg, Nedlands, Randwick
2025-06-10
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Garran, Camperdown, North Ryde, Westmead, Chelmer, Chermside, Greenslopes, South Brisbane
2025-06-09
Recruiting
National Cancer Institute (NCI)
Phase 2
222
Hunter Regional Mail Centre, South Brisbane, Parkville, Perth
2025-05-30
Active, closed
Paradigm Biopharmaceuticals Ltd.
Phase 3
466
Brookvale, Charlestown, Miranda, Wollongong, South Brisbane, Southport, Adelaide, Stepney
2025-05-29
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
DrugsSPY001·SPY002·SPY003
Spyre Therapeutics, Inc.
Phase 2
645
Murdoch, Concord, Heidelberg, Liverpool, Melbourne, South Brisbane, Woolloongabba
2025-05-27
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NCT06881784NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer, NSCLC, NSCLC (Non-small Cell Lung Carcinoma)
DrugsCetuximab·Docetaxel
Revolution Medicines, Inc.
Phase 3
590
Blacktown, Camperdown, Kogarah, Waratah, South Brisbane, Melbourne, Perth
2025-05-06
Recruiting
AstraZeneca
Phase 3
1,220
Camperdown, Clayton, Heidelberg, Randwick, South Brisbane
2025-05-06
Recruiting
AbbVie
Phase 2
390
Sydney, South Brisbane, Woodville South, Heidelberg, Nedlands
2025-04-24
Recruiting
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
NCT06401330Stage I Mixed Cell Type Kidney Wilms Tumor, Stage II Mixed Cell Type Kidney Wilms Tumor, Stage III Mixed Cell Type Kidney Wilms Tumor, Stage IV Mixed Cell Type Kidney Wilms Tumor
DrugsDactinomycin·Vincrystine·Cytoxan·Paraplatin
Children's Oncology Group
Phase 3
1,656
South Brisbane
2025-04-15
Recruiting
Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
NCT06510699Fungal Infection, Haematological Malignancy, Blood Cancer, Infectious Disease
The University of Queensland
Phase 2
104
Sydney, Brisbane, South Brisbane, Adelaide, Melbourne
2025-04-14
Recruiting
Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003
NCT06714006Autosomal Dominant Polycystic Kidney Disease (ADPKD)
PYC Therapeutics
Phase 1
166
Southport, Concord, Liverpool, Randwick, Wahroonga, Westmead, South Brisbane, Fitzroy
2025-04-07
Recruiting
AstraZeneca
Phase 3
600
Blacktown, East Melbourne, Nedlands, South Brisbane
2025-03-27
Recruiting
Hoffmann-La Roche
Phase 3
600
Garran, Sydney, Herston, South Brisbane, Woolloongabba, Adelaide, Epping, Murdoch
2025-03-17
Recruiting
Akeso
Phase 1
100
Blacktown, North Ryde, South Brisbane, Frankston
2025-02-24
Recruiting
CStone Pharmaceuticals
Phase 1/2
800
Melbourne, South Brisbane, Sydney
2025-02-24
Active, closed
Genmab
Phase 3
584
New Lambton Heights, South Brisbane, Subiaco
2025-02-07
Recruiting
Study of Olutasidenib and Temozolomide in HGG
NCT06161974High Grade Glioma, Astrocytoma, Astrocytoma, Grade III, Astrocytoma, Grade IV
DrugOlutasidenib
Rigel Pharmaceuticals
Phase 2
60
Randwick, South Brisbane, Perth
2025-02-01
Active, closed
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
NCT06710132Solid Tumors, Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer
DrugM9140
EMD Serono Research & Development Institute, Inc.
Phase 1/2
184
Bedford Park, Kingswood, South Brisbane, Sydney
2025-01-29
Active, closed
Amgen
Phase 2
61
St Leonards, Waratah, South Brisbane, Adelaide
2024-12-26
Recruiting
BeOne Medicines
Phase 1
168
Blacktown, Liverpool, South Brisbane, Clayton, Malvern
2024-12-09
Recruiting
BeOne Medicines
Phase 1/2
80
Kogarah, South Brisbane, Clayton, Melbourne, Nedlands
2024-11-27
Active, closed
BioMarin Pharmaceutical
Phase 2
30
Saint Leonards, South Brisbane, Parkville
2024-11-22
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
50
Nedlands, Parkville, South Brisbane
2024-11-21
Active, closed
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
NCT06422884Idiopathic Pulmonary Fibrosis, Progressive Fibrosing Interstitial Lung Disease
DrugTaladegib
Endeavor Biomedicines, Inc.
Phase 2
213
Camperdown, Macquarie Park, Brisbane, South Brisbane, Box Hill, Nedlands
2024-11-15
Active, closed
AbbVie
Phase 2
74
South Brisbane
2024-11-08
Recruiting
A Study of DM005 in Patients With Advanced Solid Tumors
NCT06515990Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of Head and Neck, Solid Carcinoma
Doma Biopharmaceutical（Suzhou）Co., Ltd.
Phase 1/2
208
Camperdown, North Ryde, South Brisbane
2024-10-31
Recruiting
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
NCT06663332Crohns Disease, Colitis, Ulcerative, Arthritis, Psoriatic, Arthritis, Juvenile
DrugGuselkumab
Janssen Research & Development, LLC
Phase 3
196
Nedlands, South Brisbane, Westmead
2024-10-29
Recruiting
Shanghai Allink Biotherapeutics Co., Ltd.
Phase 1/2
202
Wollongong, Birtinya, South Brisbane, Macquarie
2024-10-24
Active, closed
A Study of DM001 in Patients With Advanced Solid Tumors
NCT06475937Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Solid Carcinoma
Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
Phase 1
128
South Brisbane, Southport, Clayton
2024-10-24
Recruiting
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
NCT06368817Basal Ganglia Germinoma, Diabetes Insipidus, Germinoma, Pineal Region Germinoma
DrugsParaplatin·Etoposide·Carboplatin
Children's Oncology Group
Phase 2
240
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Parkville, Perth
2024-10-22
Active, closed
Uniquity One (UNI)
Phase 2
184
Newcastle, Maroochydore, South Brisbane, Woolloongabba, Box Hill, Fitzroy, Parkville, Murdoch
2024-10-16
Recruiting
Xencor, Inc.
Phase 1/2
270
Adelaide, Joondalup, Melbourne, Nedlands, South Brisbane, Southport, Wollongong
2024-10-10
Recruiting
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
NCT06561048Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma, Follicular T-Cell Lymphoma, Nodal Peripheral T-Cell Lymphoma With TFH Phenotype
DrugsBelinostat·Pralatrexate·Soquelitinib
Corvus Pharmaceuticals, Inc.
Phase 3
150
Darlinghurst, Kogarah, South Brisbane, Adelaide, Bedford Park, Hobart, Box Hill, Heidelberg
2024-10-02
Active, closed
Hoffmann-La Roche
Phase 3
400
Garran, Sydney, South Brisbane, Adelaide, Murdoch
2024-09-17
Active, closed
Celgene
Phase 2
95
Liverpool, South Brisbane, Traralgon
2024-08-30
Active, closed
Gilead Sciences
Phase 3
640
Canberra, Camperdown, South Brisbane, Clayton, Melbourne, Murdoch
2024-08-28
Recruiting
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
NCT05843253High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma, Glioblastoma
DrugsEverolimus·Ribociclib·Temozolomide
Nationwide Children's Hospital
Phase 2
120
Randwick, South Brisbane, Melbourne, Perth
2024-08-22
Recruiting
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2
69
Garran, Albury, Darlinghurst, St Leonards, Wahroonga, Chermside, South Brisbane, Adelaide
2024-08-14
Active, closed
Sanofi
Phase 1
144
Morayfield, Sippy Downs, South Brisbane, Bayswater
2024-08-13
Recruiting
AbbVie
Phase 3
110
Randwick, Westmead, South Brisbane, Clayton, Perth
2024-08-08
Recruiting
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
NCT06257706Moderately to Severely Active Crohn's Disease, Crohn Disease, Disease Crohn
DrugVedolizumab
Alimentiv Inc.
Phase 4
304
Concord, South Brisbane, Adelaide, Woodville, Epping, Heidelberg, Melbourne, Murdoch
2024-08-07
Recruiting
Targeted Pediatric High-Grade Glioma Therapy
NCT05839379High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma, Glioblastoma
Nationwide Children's Hospital
Observational
350
Randwick, South Brisbane, Melbourne, Perth
2024-08-02
Active, closed
Ultragenyx Pharmaceutical Inc
Phase 3
255
South Brisbane, Melbourne
2024-07-31
Active, closed
GRIN Therapeutics, Inc.
Phase 1/2
30
South Brisbane
2024-07-10
Recruiting
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 3
264
Camperdown, Birtinya, South Brisbane, City of Burnside, Box Hill, Southport
2024-06-25
Active, closed
Sanofi
Phase 2
185
Chermside, South Brisbane, North Adelaide, Box Hill, Fitzroy, Frankston
2024-06-20
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
DrugPegozafermin
89bio, Inc.
Phase 3
762
Adelaide, Fitzroy, Greenslopes, Heidelberg, Herston, Murdoch, Perth, South Brisbane
2024-05-24
Recruiting
AstraZeneca
Phase 3
582
Camperdown, Clayton, Kogarah, South Brisbane, Westmead
2024-04-29
Recruiting
National Cancer Institute (NCI)
Phase 3
478
Randwick, Westmead, South Brisbane, Parkville, Perth
2024-04-19
Active, closed
Janssen-Cilag Ltd.
Phase 3
120
Adelaide, Concord, Melbourne, Murdoch, South Brisbane
2024-04-17
Recruiting
AstraZeneca
Phase 3
675
Birtinya, Blacktown, Clayton, Gosford, Melbourne, South Brisbane, Wodonga
2024-04-11
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
43
South Brisbane
2024-04-02
Active, closed
Takeda
Phase 2
213
Sydney, South Brisbane, Bedford Park, Woodville, Melbourne, Nedlands, Perth, Murdoch
2024-03-29
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
230
Macquarie University, Westmead, South Brisbane, Nedlands
2024-03-28
Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
NCT05828069Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
DrugTovorafenib
National Cancer Institute (NCI)
Phase 2
48
Randwick, South Brisbane, Parkville, Perth
2024-03-28
Active, closed
Gilead Sciences
Phase 2
228
Sydney, South Brisbane, Woolloongabba, Woodville, Clayton, Epping, Fitzroy, Footscray
2024-03-27
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
DrugPegozafermin
89bio, Inc.
Phase 3
1,350
Brisbane, Herston, South Brisbane, Adelaide, Bedford Park, Clayton, Heidelberg, Perth
2024-03-13
Recruiting
Janssen Research & Development, LLC
Phase 3
120
Nedlands, South Brisbane, Westmead
2024-03-13
Recruiting
Takeda
Phase 2
268
Concord, South Brisbane, Bedford Park, Woodville, Footscray, Murdoch, Perth, Epping
2024-03-05
By invitation
Sarepta Therapeutics, Inc.
Phase 1/2
78
Liverpool, Birtinya, Herston, Melbourne, South Brisbane
2024-03-04
Active, closed
NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)
NCT05996003Duchenne Muscular Dystrophy, Exon 44, DMD
DrugBrogidirsen
NS Pharma, Inc.
Phase 2
20
South Brisbane, Nedlands
2024-02-22
Active, closed
AbbVie
Observational
1,200
Blacktown, Macquarie University, South Brisbane, Kurralta Park, Woodville South, Clayton, Melbourne
2024-02-19
Recruiting
Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency
NCT04706013Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency
Medicure
Phase 3
15
South Brisbane
2024-02-16
Recruiting
OnCusp Therapeutics, Inc.
Phase 1
263
South Brisbane
2024-02-09
Active, closed
BicycleTx Limited
Phase 2
375
Adelaide, Brisbane, Douglas, Geelong, Hunter, Nedlands, New South Wales, South Brisbane
2024-01-24
Recruiting
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
NCT06137144Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Peripheral T-cell Lymphoma (PTCL)
DrugsAZD3470·Keytruda·Pembrolizumab
AstraZeneca
Phase 1/2
161
Adelaide, Birtinya, Fitzroy, Nedlands, South Brisbane, Waratah
2024-01-23
Active, closed
Janssen Research & Development, LLC
Phase 3
112
Nedlands, South Brisbane, Westmead
2024-01-19
Active, closed
DualityBio Inc.
Phase 3
541
Camperdown, Kingswood, Liverpool, Sydney, Birtinya, South Brisbane, Southport, Townsville
2024-01-18
Recruiting
Janssen Research & Development, LLC
Phase 3
120
South Brisbane, Sydney
2023-12-20
Active, closed
Syndax Pharmaceuticals
Phase 2
145
Camperdown, Birtinya, Brisbane, South Brisbane, Southport, West Mackay, Clayton, Perth
2023-12-11
Active, closed
Hoffmann-La Roche
Phase 3
1,050
Frenchs Forest, Kingswood, North Sydney, Buderim, South Brisbane, Adelaide, Geelong, St Albans
2023-12-11
Recruiting
Eikon Therapeutics
Phase 1/2
156
Randwick, South Brisbane, Southport, Sydney, Woolloongabba, Frankston
2023-12-11
Active, closed
Gilead Sciences
Phase 2
176
Birtinya, South Brisbane, Woolloongabba, Adelaide, Woodville, Epping, Murdoch
2023-12-05
Active, closed
AstraZeneca
Phase 3
1,898
Chermside, Darlinghurst, Hyde Park, Kurralta Park, Melbourne, South Brisbane
2023-11-21
Active, closed
Kite, A Gilead Company
Phase 1
21
Camperdown, South Brisbane, Melbourne
2023-11-09
Active, closed
AbbVie
Phase 3
122
Westmead, South Brisbane, Clayton, Perth
2023-11-06
Recruiting
LeonaBio
Phase 3
600
Blacktown, Concord, South Brisbane
2023-10-31
Active, closed
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 2
74
South Brisbane, Melbourne
2023-10-30
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Camperdown, Westmead, Brisbane, Greenslopes, South Brisbane, Adelaide, Box Hill, Heidelberg,VIC
2023-10-25
Active, closed
AstraZeneca
Phase 3
895
Clayton, Fitzroy, Heidelberg, South Brisbane, Sydney
2023-10-24
Active, closed
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 2
78
Saint Leonards, South Brisbane, Adelaide, Melbourne, Parkville, Nedlands
2023-10-19
Recruiting
Phase 1 Study of AWT020 in Advanced Cancer
NCT06092580Advanced Cancer
DrugAWT020
Anwita Biosciences
Phase 1
60
South Brisbane, Bedford Park, Clayton, Melbourne
2023-09-15
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Camperdown, Westmead, Brisbane, Greenslopes, South Brisbane, Adelaide, Box Hill, Frankston
2023-09-14
Active, closed
Boehringer Ingelheim
Phase 2
268
Macquarie Park, Westmead, Chermside, South Brisbane, Nedlands, Spearwood
2023-09-08
Active, closed
Janssen Research & Development, LLC
Phase 3
420
Macquarie University, Melbourne, South Brisbane
2023-08-31
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 3
2,772
Box Hill, Clayton, Melbourne, Midland, Nedlands, North Adelaide, Parkville, South Brisbane
2023-08-30
By invitation
Vertex Pharmaceuticals Incorporated
Phase 3
174
Nedlands, North Adelaide, Parkville, South Brisbane
2023-08-11
Recruiting
FOG-001 in Locally Advanced or Metastatic Solid Tumors
NCT05919264Cancer, Colorectal Cancer, Solid Tumor, Locally Advanced Solid Tumor
DrugsLonsurf·MFOLFOX6·Trifluridine/Tipiracil·Avastin
Parabilis Medicines, Inc.
Phase 1/2
619
South Brisbane, Melbourne
2023-05-23
Active, closed
Grey Wolf Therapeutics
Phase 1/2
300
Bedford Park, Blacktown, Darlinghurst, Heidelberg, Melbourne, South Brisbane, Wollongong
2023-05-21
Recruiting
Takeda
Phase 3
240
Westmead, South Brisbane, Clayton, Parkville
2023-05-16
By invitation
An Open-label Study of XEN1101 in Epilepsy
NCT05718817Focal Epilepsy, Tonic-Clonic Seizures
DrugAzetukalner
Xenon Pharmaceuticals Inc.
Phase 3
880
Randwick, Camperdown, Fitzroy, Heidelberg, Kogarah, Melbourne, Parkville, South Brisbane
2023-04-25
Recruiting
GlaxoSmithKline
Phase 3
138
South Brisbane, North Adelaide, Joondalup WA
2023-04-24
Recruiting
MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
NCT05286788Adamantinous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma
DrugBinimetinib
Nationwide Children's Hospital
Phase 2
38
Randwick, South Brisbane, Perth
2023-04-10
Recruiting
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
NCT05735080Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
DrugsAbemaciclib·Fulvestrant
Incyclix Bio
Phase 1/2
150
Frankston, Parkville, South Brisbane
2023-03-28
Recruiting
A Study of ATG-022 in Patients With Advanced/Metastatic Solid Tumors
NCT05718895Advanced/Metastatic Solid Tumors
DrugATG-022
Antengene Biologics Limited
Phase 1
156
Adelaide, Malvern, South Brisbane
2023-03-27
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
Heidelberg, Macquarie University, Nedlands, South Brisbane
2023-03-23
Active, closed
Merck Sharp & Dohme LLC
Phase 2
129
Camperdown, Westmead, Auchenflower, Brisbane, South Brisbane
2023-03-16
Active, closed
GRIN Therapeutics, Inc.
Phase 1
24
South Brisbane
2023-03-07
Active, closed
DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)
NCT05566795Low-grade Glioma, Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma, Pediatric Low-grade Glioma
DrugsTovorafenib·Carboplatin
Day One Biopharmaceuticals, Inc.
Phase 3
418
South Brisbane, Nedlands, North Adelaide, Parkville, Randwick, Westmead
2023-02-27
Active, closed
DBV Technologies
Phase 3
600
Adelaide, Nedlands, Parkville, Richmond, South Brisbane, Westmead
2023-02-21
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
160
Kogarah, South Brisbane, Melbourne, Heidelberg, Parkville
2023-02-14
Active, closed
Kite, A Gilead Company
Phase 3
300
Camperdown, South Brisbane, Melbourne
2023-02-10
Active, closed
A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy
NCT05621317Peanut Allergy, Peanut Hypersensitivity, Peanut-Induced Anaphylaxis, Immune System Diseases
Aravax Pty Ltd
Phase 2
90
Randwick, Westmead, South Brisbane, North Adelaide, Parkville, Nedlands
2023-02-09
Recruiting
Canadian Cancer Trials Group
Phase 2
393
Liverpool, St Leonards, Waratah, Westmead, South Brisbane, Darwin, Clayton, Frankston
2022-12-19
Recruiting
ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
NCT05233397Adamantinomatous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma
DrugTocilizumab
Nationwide Children's Hospital
Phase 2
30
Randwick, South Brisbane, Perth
2022-12-16
Recruiting
Princess Maxima Center for Pediatric Oncology
Phase 3
160
Clayton, Adelaide, New Lambton Heights, Parkville, Perth, South Brisbane, Sydney, Westmead
2022-12-15
Recruiting
AstraZeneca
Phase 3
3,527
Adelaide, Bedford Park, New Lambton Heights, Port Macquarie, South Brisbane
2022-12-13
Active, closed
Celcuity Inc
Phase 3
701
Adelaide, Fitzroy, Frankston, Nedlands, South Brisbane, Southport, Wahroonga, Woodville
2022-12-08
Active, closed
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
NCT05611671Inflammatory Bowel Diseases, Colitis, Ulcerative
DrugZotemtegrast
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
280
Blacktown, Concord, Herston, Murdoch, South Brisbane
2022-11-21
Active, closed
Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors
NCT05286801Atypical Teratoid/Rhabdoid Tumor, Epithelioid Sarcoma, Kidney Medullary Carcinoma, Malignant Solid Neoplasm
DrugsTiragolumab·Tecentriq·Atezolizumab
National Cancer Institute (NCI)
Phase 1/2
86
Randwick, South Brisbane, Parkville
2022-11-17
Recruiting
Hoffmann-La Roche
Phase 1/2
65
South Brisbane, Nedlands
2022-11-16
Active, closed
Vincristine Pharmacokinetics in Infants
NCT05359237Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
DrugsVincrystine·Vincristine
Children's Oncology Group
Observational
83
South Brisbane
2022-11-16
Active, closed
AstraZeneca
Phase 3
368
Elizabeth Vale, Kogarah, South Brisbane, Woolloongabba
2022-11-10
Recruiting
Leiden University Medical Center
Phase 2
168
Albury, Camperdown, Kogarah, Newcastle, St Leonards, Wahroonga, Birtinya, South Brisbane
2022-11-10
Recruiting
Bayer
Phase 3
100
South Brisbane, Clayton, Parkville
2022-11-08
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
822
Camperdown, Chermside, Melbourne, Nedlands, Parkville, South Brisbane, Westmead
2022-11-08
Recruiting
Stalicla SA
Observational
1,500
South Brisbane, Bedford Park, Melbourne, Parkville
2022-10-13
Recruiting
PedAL BCU, LLC
Phase 3
130
South Brisbane, Parkville, Nedlands
2022-10-01
Active, closed
AstraZeneca
Phase 3
594
Elizabeth Vale, Lismore, Murdoch, South Brisbane, Wollongong
2022-09-15
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Adelaide, Camperdown, Clayton, Herston, Murdoch, Parkville, South Brisbane, Woodville South
2022-09-13
By invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
NCT04905693Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Progressive Pulmonary Fibrosis
DrugTreprostinil
United Therapeutics
Phase 3
1,850
Camperdown, Macquarie Park, Westmead, Cairns, Chermside, South Brisbane, Melbourne
2022-09-06
Active, closed
Biogen
Phase 2
416
Camperdown, Darlinghurst, Kogarah, Liverpool, South Brisbane
2022-08-24
Active, closed
Gilead Sciences
Phase 3
443
Albury, Kogarah, North Sydney, St Leonards, South Brisbane, Woolloongabba, Adelaide, Hobart
2022-07-25
Active, closed
Gilead Sciences
Phase 3
623
Kogarah, South Brisbane, Woolloongabba, Adelaide, Clayton, Melbourne, Nedlands
2022-07-20
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
210
Nedlands, North Adelaide, Parkville, South Brisbane
2022-06-21
Active, closed
Novartis Pharmaceuticals
Phase 3
95
Auchenflower, South Brisbane
2022-06-15
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
372
Alexandria, St Leonards, Sydney, Brisbane, South Brisbane, Frankston, Elizabeth Vale
2022-05-03
Recruiting
SK Life Science, Inc.
Phase 3
252
Heidelberg, Melbourne, Nedlands, South Brisbane
2022-04-28
Recruiting
PedAL BCU, LLC
Phase 1/2
960
Westmead, South Brisbane, Parkville, Perth
2022-04-18
Active, closed
Eli Lilly and Company
Phase 3
925
Camperdown, Coffs Harbour, Darlinghurst, Liverpool, Macquarie University, South Brisbane, Southport, Woolloongabba
2022-04-14
Active, closed
Bayer
Phase 3
219
South Brisbane, Clayton, Parkville
2022-03-28
Active, closed
Setrusumab vs Placebo for Osteogenesis Imperfecta
NCT05125809Osteogenesis Imperfecta
DrugSetrusumab
Ultragenyx Pharmaceutical Inc
Phase 2/3
183
South Brisbane, Melbourne
2022-02-21
Recruiting
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 2
310
Chermside, South Brisbane, Adelaide, Toorak Gardens, East Melbourne, Nedlands, Subiaco
2022-02-17
Recruiting
Takeda
Phase 3
120
Westmead, South Brisbane, Clayton, Parkville
2022-02-10
Active, closed
AstraZeneca
Phase 3
1,051
Box Hill, East Melbourne, Elizabeth Vale, Gosford, Heidelberg, Kogarah, South Brisbane, St Albans
2022-02-07
By invitation
UCB Biopharma SRL
Phase 3
300
Fitzroy, Herston, South Brisbane
2022-02-03
Recruiting
DualityBio Inc.
Phase 1/2
796
Randwick, Sydney, South Brisbane, Melbourne
2022-01-31
Active, closed
SK Life Science, Inc.
Phase 3
140
Parkville, Randwick, South Brisbane
2022-01-10
Active, closed
Olema Pharmaceuticals, Inc.
Phase 1
60
Waratah, Westmead, South Brisbane, Southport, Clayton, Frankston, Geelong, Nedlands
2021-12-10
Recruiting
UCB Biopharma SRL
Phase 3
350
Fitzroy, Herston, Melbourne, South Brisbane
2021-12-07
Recruiting
Combination Therapy for the Treatment of Diffuse Midline Gliomas
NCT05009992Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant, Recurrent Diffuse Intrinsic Pontine Glioma, Recurrent Diffuse Midline Glioma, H3 K27M-Mutant
DrugsDNX-2401·Dordaviprone·Paxalisib
University of California, San Francisco
Phase 2
360
New Lambton Heights, Westmead, South Brisbane, Clayton, Melbourne, Nedlands, Adelaide, Sydney
2021-10-20
Active, closed
AbbVie
Phase 1
520
South Brisbane, Heidelberg
2021-10-13
Active, closed
National Cancer Institute (NCI)
Phase 3
244
Hunter Regional Mail Centre, Westmead, South Brisbane, Parkville, Perth
2021-10-05
Active, closed
HUYABIO International, LLC.
Phase 3
450
Wahroonga, Buderim, South Brisbane, Ballarat, Shepparton, Brisbane, Liverpool, Nedlands
2021-08-12
Recruiting
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
NCT04684368Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma, Embryonal Carcinoma, Immature Teratoma
DrugsUromitexan·Tripegfilgrastim·Mesna·Isophosphamide
Children's Oncology Group
Phase 2
160
Randwick, Westmead, South Brisbane, North Adelaide, Parkville, Perth
2021-07-13
Active, closed
Murdoch Childrens Research Institute
Not applicable
906
South Brisbane, Adelaide, Melbourne, Parkville, Subiaco
2021-05-04
Active, closed
Merck Sharp & Dohme LLC
Phase 3
808
Macquarie University, South Brisbane, Elizabeth Vale, Frankston
2021-04-21
Recruiting
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
NCT04655404High Grade Glioma, Diffuse Intrinsic Pontine Glioma
DrugLarotrectinib
Nationwide Children's Hospital
Early Phase 1
15
Randwick, South Brisbane, Perth
2021-04-08
Recruiting
Management of Type 1 Supracondylar Humeral Fractures
NCT04642807Elbow Fracture, Trauma
University of British Columbia
Not applicable
52
South Brisbane
2021-04-01
Active, closed
Karyopharm Therapeutics Inc
Phase 3
353
Bankstown, Campbelltown, Liverpool, South Brisbane, Adelaide, Nedlands
2021-03-11
Active, closed
Bioverativ, a Sanofi company
Phase 3
261
Camperdown, Westmead, South Brisbane, Murdoch
2021-02-23
Active, closed
ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND)
NCT05388708Acute Respiratory Distress Syndrome, Extracorporeal Membrane Oxygenation
University of Michigan
Observational
550
Melbourne, Perth, South Brisbane, Westmead
2021-02-04
Recruiting
Sentinel Node Biopsy in Endometrial Cancer
NCT04073706Endometrial Cancer Stage I, Sentinel Lymph Node, Surgery
Queensland Centre for Gynaecological Cancer
Phase 3
760
Camperdown, Liverpool, Auchenflower, Brisbane, Buderim, Everton Park, Herston, South Brisbane
2021-01-18
Active, closed
Genmab
Phase 3
483
Bedford Park, Concord, Frankston, South Brisbane, Waratah, Westmead
2021-01-13
Active, closed
Amgen
Phase 1/2
181
Randwick, Westmead, South Brisbane, Adelaide, Clayton, Heidelberg, Melbourne, Nedlands
2021-01-04
Active, closed
Children's Oncology Group
Phase 2
41
Westmead, South Brisbane, Parkville, Perth
2020-12-31
Recruiting
National Cancer Institute (NCI)
Phase 2
461
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, Perth
2020-12-17
Active, closed
GlaxoSmithKline
Phase 2/3
758
South Brisbane, Ashford, Hobart, Ballarat, Melbourne, Mount Waverley
2020-12-08
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
NCT04585750Advanced Solid Tumor, Advanced Malignant Neoplasm, Metastatic Cancer, Metastatic Solid Tumor
DrugsRezatapopt·Keytruda·Pembrolizumab
PMV Pharmaceuticals, Inc
Phase 1/2
300
Camperdown, South Brisbane, Bedford Park, Clayton, Nedlands
2020-10-29
Recruiting
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
NCT04516447Solid Tumor, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
DrugsAzenosertib·Pegylated liposomal doxorubicin·Gemcitabine·Paclitaxel
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 1
172
South Brisbane, Sunshine Coast, Adelaide, Melbourne, Nedlands
2020-10-26
Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
NCT04322318Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor, Stage II Kidney Wilms Tumor, Stage III Kidney Wilms Tumor
DrugsIsophosphamide·Vincrystine·Ifosfamide·Topotecan
Children's Oncology Group
Phase 2
256
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Clayton, Parkville, Perth
2020-10-19
Active, closed
Hoffmann-La Roche
Phase 3
992
Waratah, South Brisbane, Woolloongabba, Melbourne, St Albans, Murdoch
2020-10-09
Active, closed
A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery
NCT04195399Desmoid Fibromatosis, Recurrent Desmoid Fibromatosis, Unresectable Desmoid Fibromatosis
DrugNirogacestat
Children's Oncology Group
Phase 2
31
Westmead, South Brisbane, Perth
2020-10-07
Active, closed
Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults
NCT04323046Glioblastoma, Malignant Glioma, Recurrent Glioblastoma, Recurrent Malignant Glioma
DrugsOpdivo·Nivolumab
Sabine Mueller, MD, PhD
Phase 1
9
Sydney, Westmead, South Brisbane, North Adelaide, Parkville, Perth
2020-10-02
Active, closed
GlaxoSmithKline
Phase 3
302
Garran, Darlinghurst, Gosford NSW, Port Macquarie, Benowa, South Brisbane, Adelaide, Fitzroy
2020-10-01
Active, closed
AbbVie
Phase 3
527
Wollongong, South Brisbane, Southport, Elizabeth Vale, Clayton
2020-09-30
Active, closed
AstraZeneca
Phase 3
866
Adelaide, Birtinya, Darlinghurst, Murdoch, South Brisbane, St Leonards, Waratah
2020-07-24
Recruiting
Children's Oncology Group
Phase 3
1,400
Randwick, Westmead, South Brisbane, Perth
2020-07-21
Active, closed
AstraZeneca
Phase 3
1,012
Birtinya, Darlinghurst, Kingswood, Orange, South Brisbane
2020-07-13
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
886
Box Hill, Douglas, Heidelberg, Macquarie Park, South Australia, South Brisbane
2020-03-30
Recruiting
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
NCT04094610Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma, Primary CNS Tumors
DrugRepotrectinib
Turning Point Therapeutics, Inc.
Phase 1/2
75
Randwick, Westmead, South Brisbane, Nedlands
2020-03-12
Recruiting
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
NCT04310930Pulmonary Disease Due to Mycobacteria (Diagnosis)
DrugsImipenem·Co-trimoxazole·Rifabutin·Tigecycline
The University of Queensland
Phase 2/3
300
Kogarah, South Brisbane, Woolloongabba, Heidelberg, Parkville, Perth, Adelaide, Birtinya
2020-03-02
Active, closed
Hoffmann-La Roche
Phase 2/3
325
Macquarie Park, Wollongong, South Brisbane, Woolloongabba, Fitzroy, Frankston
2020-01-29
Active, closed
Actelion
Phase 3
138
South Brisbane
2020-01-16
Active, closed
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
NCT04185883Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation
DrugsBI 1701963·TNO155·Sotorasib·Afatinib
Amgen
Phase 1
610
Kingswood, St Leonards, South Brisbane, Woodville South, Subiaco
2019-12-17
Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
NCT03959085B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Central Nervous System Leukemia, Mixed Phenotype Acute Leukemia
DrugsCalaspargase Pegol·Tioguanin·Thioguanine·Oncaspar
Children's Oncology Group
Phase 3
5,951
Hunter Regional Mail Centre, Westmead, South Brisbane, North Adelaide, Saint Hobart, Clayton, Parkville, Perth
2019-10-31
Active, closed
Gilead Sciences
Phase 2
227
Bowral, North Ryde, Waratah, Westmead, Benowa, South Brisbane, Elizabeth Vale, Clayton
2019-10-15
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Camberwell, Clayton, Footscray, Murdoch, Perth, South Brisbane, Subiaco, Woolloongabba
2019-09-26
Active, closed
BeOne Medicines
Phase 3
510
Garran, Concord, Cudgen, Darlinghurst, Gosford, Waratah, Birtinya, South Brisbane
2019-08-20
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
NCT04064060Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
DrugLuspatercept
Celgene
Phase 3
665
South Brisbane, Adelaide, Clayton, Camperdown
2019-08-12
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Coffs Harbour, North Sydney, Sydney, Waratah, Westmead, Greenslopes, South Brisbane, Southport
2019-08-09
Active, closed
Merck Sharp & Dohme LLC
Phase 3
595
Blacktown, Macquarie Park, Cairns, South Brisbane, Box Hill, Clayton
2019-07-24
Active, closed
Children's Oncology Group
Phase 2
94
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Parkville, Perth
2019-07-08
Active, closed
National Cancer Institute (NCI)
Phase 3
6,720
Hunter Regional Mail Centre, Westmead, South Brisbane, North Adelaide, Clayton, Parkville, Perth
2019-07-03
Active, closed
Exelixis
Phase 3
855
Albury, Kogarah, North Ryde, Sydney, South Brisbane, Woolloongabba, Adelaide, North Adelaide
2019-06-25
Recruiting
Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction
NCT05651347Fetal Growth Retardation, Stillbirth and Fetal Death, Pregnancy Preterm
DrugMelatonin
Monash University
Phase 3
336
Camperdown, Newcastle, South Brisbane, Southport, North Adelaide, Clayton, Heidelberg, Parkville
2019-05-29
Active, closed
AbbVie
Phase 1
150
South Brisbane
2019-05-21
Active, closed
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
NCT03253263Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage, Retinopathy of Prematurity (ROP)
OHB Neonatology Ltd.
Phase 2
295
Randwick, Westmead, Parkville, South Brisbane
2019-05-09
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
1,759
Camperdown, Darlinghurst, Kingswood, New Lambton, Westmead, Herston, South Brisbane, Adelaide
2019-03-28
Active, closed
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
NCT03845166Neoplasm Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma, Metastatic Castration-resistant Prostate Cancer
DrugsZanzalintinib·Avelumab·Tecentriq·Atezolizumab
Exelixis
Phase 1
325
Darlinghurst, Liverpool, South Brisbane, Kurralta Park, Heidelberg
2019-03-20
Active, closed
AbbVie
Phase 1
364
Camperdown, South Brisbane
2019-02-21
Recruiting
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
NCT05685745Infant, Extremely Premature, Obstetric Labor, Premature, Premature Birth, Intensive Care, Neonatal
The University of Texas Health Science Center, Houston
Observational
5,000
South Brisbane, Heidelberg, Parkville, Perth
2019-01-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,240
Camperdown, Sydney, South Brisbane, Frankston, Melbourne
2018-12-27
Recruiting
Study of Individuals Affected With Hypoplasminogenemia
NCT03797495Plasminogen Deficiency
Indiana Hemophilia &Thrombosis Center, Inc.
Observational
100
Melbourne, South Brisbane
2018-12-18
Active, closed
AstraZeneca
Phase 3
1,063
Brisbane, Elizabeth Vale, Macquarie University, Melbourne, Murdoch, South Brisbane
2018-11-16
Active, closed
Children's Oncology Group
Phase 2
38
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, Clayton, Parkville, Perth
2018-11-06
Active, closed
AbbVie
Phase 3
265
Liverpool, Wahroonga, Wollongong, Hyde Park, South Brisbane, Woodville South, Nedlands
2018-10-22
Active, closed
AbbVie
Phase 2
270
Darlinghurst, Lambton Heights, Tweed Heads, South Brisbane, Subiaco
2018-10-10
Active, closed
AstraZeneca
Phase 3
1,246
Box Hill, Elizabeth Vale, Kogarah, Macquarie University, Murdoch, Orange, South Brisbane, St Albans
2018-09-27
Active, closed
A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors
NCT03611868Unresectable or Metastatic Melanoma or Advanced Solid Tumors, Melanoma, Uveal Melanoma, P53 Mutation
DrugPembrolizumab
Ascentage Pharma Group Inc.
Phase 1/2
230
Brisbane, South Brisbane, Bedford Park, Heidelberg
2018-08-29
Active, closed
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
NCT03533582Childhood Hepatocellular Carcinoma, Childhood Malignant Liver Neoplasm, Fibrolamellar Carcinoma, Hepatoblastoma
DrugsSorafenib·Cis-platinum·CDDP·Paraplatin
Children's Oncology Group
Phase 3
537
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Parkville, Perth
2018-05-24
Active, closed
Extended Access of Momelotinib in Adults With Myelofibrosis
NCT03441113Neoplasms, Post-polycythemia Vera Myelofibrosis (Post-PV MF), Primary Myelofibrosis (PMF), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
GlaxoSmithKline
Phase 2
237
South Brisbane, Bedford Park, Frankston, Melbourne, Perth
2018-05-03
Active, closed
AbbVie
Phase 3
1,336
South Brisbane, Southport, Elizabeth Vale, Camberwell
2018-04-09
Active, closed
AbbVie
Phase 3
747
Concord, North Mackay, South Brisbane, Adelaide, Box Hill, Murdoch
2018-03-21
Active, closed
Pfizer
Phase 3
1,054
Camperdown, Darlinghurst, Port Macquarie, Auchenflower, Brisbane, Chermside, South Brisbane, Southport
2017-12-18
Active, closed
Sanofi
Phase 3
475
Liverpool, Waratah, Wollongong, South Brisbane, Clayton, Heidelberg West, Nedlands, West Perth
2017-12-07
Active, closed
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
NCT03212404Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small Cell, Malignant Mesothelioma, Advanced
Checkpoint Therapeutics, Inc.
Phase 1
272
Wollongong, Benowa, Buderim, Greenslopes, South Brisbane, Woolloongabba, Box Hill, Malvern
2017-09-20
Active, closed
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
NCT03007147Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia, T Acute Lymphoblastic Leukemia
DrugsL-leucovorin·Therapeutic Hydrocortisone·Levofolinate·Isophosphamide
Children's Oncology Group
Phase 3
352
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, Perth
2017-08-08
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
518
Clayton, Darlinghurst, Garran, Melbourne, Nedlands, South Brisbane, Waratah, Westmead
2017-06-21
Recruiting
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
NCT03067181Childhood Extracranial Germ Cell Tumor, Extragonadal Embryonal Carcinoma, Germ Cell Tumor, Malignant Germ Cell Tumor
DrugsBleomycin·Cis-platinum·CDDP·Paraplatin
Children's Oncology Group
Phase 3
1,780
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, Clayton, Parkville, Perth
2017-05-25
Active, closed
Bristol-Myers Squibb
Phase 3
1,314
Waratah, Westmead, South Brisbane, Tugun, Heidelberg, Doubleview
2017-03-24
Active, closed
AbbVie
Phase 3
950
Macquarie University, South Brisbane, Southport, Clayton, Fitzroy Melbourne, Murdoch
2017-01-31
Active, closed
Eisai Inc.
Phase 3
1,069
Box Hill, Heidelberg, Hobart, Macquarie Park, South Brisbane, St Albans
2016-10-13
Active, closed
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
NCT02567435Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma, Rhabdomyosarcoma
DrugsTemsirolimus·Dactinomycin·Vinorelbine·Cytoxan
National Cancer Institute (NCI)
Phase 3
325
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, Perth
2016-06-01
Recruiting
Quality of Pediatric Resuscitation in a Multicenter Collaborative
NCT02708134Cardiac Arrest, Cardiopulmonary Arrest
Children's Hospital of Philadelphia
Observational
7,000
Westmead, Nedlands, South Brisbane
2016-05-02
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,052
Albury, Elizabeth Vale, Kogarah, Port Macquarie, South Brisbane, St Leonards
2015-11-27
Recruiting
Project: Every Child for Younger Patients With Cancer
NCT02402244Adrenal Gland Pheochromocytoma, Carcinoma In Situ, Central Nervous System Neoplasm, Childhood Immature Teratoma
Children's Oncology Group
Observational
75,000
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Saint Hobart, Clayton, Parkville
2015-11-03
Active, closed
Institute of Cancer Research, United Kingdom
Phase 2
345
Wagga Wagga, Brisbane, Douglas, South Brisbane, Hobart, Melbourne, Nedlands
2015-10-21
Active, closed
Children's Oncology Group
Phase 3
158
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Parkville, Perth
2015-07-21
Active, closed
Acerta Pharma BV
Phase 3
535
Darlinghurst, Frankston, Geelong, South Brisbane, Waratah NSW, Wollongong, Woodville
2015-06-26
By invitation
Registry of Patients With Hypophosphatasia
NCT02306720Hypophosphatasia (HPP)
Alexion Pharmaceuticals, Inc.
Observational
1,571
Clayton, Parkville, Herston, South Brisbane
2015-01-20
Active, closed
Eli Lilly and Company
Phase 3
493
Camperdown, Sydney, Wahroonga, South Brisbane, Woolloongabba, Woodville, Geelong, Murdoch
2014-11-06
Active, closed
Karyopharm Therapeutics Inc
Phase 2
244
Darlinghurst, Liverpool, Waratah, South Brisbane, Adelaide, Kurralta Park, Clayton, East Melbourne
2014-11
Active, closed
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
NCT02112916Adult T Acute Lymphoblastic Leukemia, Ann Arbor Stage II Adult Lymphoblastic Lymphoma, Ann Arbor Stage II Childhood Lymphoblastic Lymphoma, Ann Arbor Stage III Adult Lymphoblastic Lymphoma
DrugsHydrocortisone Sodium Succinate·Isophosphamide·Tioguanin·Thioguanine
National Cancer Institute (NCI)
Phase 3
847
Hunter Regional Mail Centre, Westmead, South Brisbane, North Adelaide, Clayton, Parkville, Perth
2014-10-04
Active, closed
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
NCT02176967Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Neuroblastoma
DrugsDoxorubicin Hydrochloride·Adriamycin·Daunorubicin·Cytoxan
Children's Oncology Group
Phase 3
391
Hunter Regional Mail Centre, Randwick, Westmead, South Brisbane, North Adelaide, Perth
2014-08-08
Active, closed
Eli Lilly and Company
Phase 3
669
South Brisbane, Southport, Kurralta Park, East Bentleigh, Subiaco
2014-07-22
Recruiting
University of Sydney
Phase 3
500
Newcastle, St Leonards, Sydney, Wahroonga, Brisbane, South Brisbane, Woolloongabba, Adelaide
2014-02
Active, closed
AbbVie
Observational
8,250
Garran, Camperdown, Concord, East Lismore, New Lambton, Herston, South Brisbane, Adelaide
2013-04-29
Recruiting
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Melbourne, Perth, Randwick, South Brisbane, Sydney
2013-04
Active, closed
Improving the Treatment for Women With Early Stage Cancer of the Uterus
NCT01686126Complex Endometrial Hyperplasia With Atypia, Grade 1 Endometrial Endometrioid Adenocarcinoma
DrugsLevonorgestrel·Mirena·Metformin
Queensland Centre for Gynaecological Cancer
Phase 2
165
Camperdown, Auchenflower, Brisbane, Greenslopes, South Brisbane, Southport, Townsville, Adelaide
2012-12
Rows per page Showing 1–308 of 308
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/south-brisbane

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 308 of those studies with a site in South Brisbane.

How many clinical trials are recruiting in South Brisbane?

157 of the 308 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 4 have not yet opened recruitment, 139 are active but closed to new participants, and 8 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (South Brisbane), 308 studies
PhaseStudiesRecruitingShare
Phase 31546950%
Phase 2693522.4%
Phase 1/229219.4%
Phase 128159.1%
Observational1374.2%
Phase 2/3952.9%
Not applicable321%
Early Phase 1220.6%
Phase 4110.3%

Most active sponsors

Lead sponsors with the most studies (South Brisbane)
Lead sponsorStudiesRecruiting
AstraZeneca2213
AbbVie184
Children's Oncology Group178
Janssen Research & Development, LLC116
National Cancer Institute (NCI)94
Hoffmann-La Roche84
Merck Sharp & Dohme LLC72
Nationwide Children's Hospital77
Sanofi74
Gilead Sciences60
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.